Thymomas (Ts) and thymic carcinomas (TCs) are rare tumours of the mediastinum with an
incidence rate of 1.7/million per year in Europe. Histological classification is based on rate of …

Introduction Thymic epithelial tumors are rare and are classified as thymoma, thymic
carcinoma, and thymic neuroendocrine tumors. The objective of this systematic review was …

Objectives The objectives of this collaborative study were to characterize patients with
thymic carcinoma, their treatment patterns, and association with overall survival (OS) and …

This study aimed to identify the trends in the incidence of thymic cancer, ie, thymoma, thymic
carcinoma, and thymic neuroendocrine tumor, in the United States. Data from the United …

Introduction The optimal role for postoperative radiotherapy (PORT) for thymoma and thymic
carcinoma remains controversial. We used the National Cancer Data Base to investigate the …

Introduction: Thymic carcinoma is a rare and aggressive thymic neoplasm. The European
Society of Thoracic Surgeons developed a retrospective database collecting patients …

OBJECTIVES Thymic carcinoma is a rare thymic malignancy. The purpose of this study was
to evaluate the prognostic impact of clinicopathological variables and perioperative therapy …

BACKGROUND The efficacy of postoperative radiotherapy (PORT) for thymic epithelial
tumors is still controversial. Using the Japanese Association for Research on the Thymus …

Purpose Thymic malignancies, comprising thymoma and thymic carcinoma, are rare.
Consequently, optimal chemotherapy for advanced thymic malignancies remains …

Introduction To report the trends in incidence and survival associated with thymic epithelial
tumors (TETs) in Korea. Methods Data from 1999 to 2017 were obtained from the Korean …